A landmark follow-up study found that heart attack survivors who receive implanted cardioverter defribillators (ICDs) live longer the longer they have them, according to the results of late-breaking clinical trail presented today at the annual Scientific Sessions of the Heart Rhythm Society.

While ICDs—implantable cardioverter defibrillators—are the device of choice to manage abnormal heart rhythms, a new study led by cardiologists at the University of Pennsylvania School of Medicine suggests that women with ICDs fare less well than their male counterparts.

Women who might have benefited from the use of an implantable heart monitor following a cardiac arrest were far less likely than men to have one prescribed, according to experts at the Duke University Medical Center.

Many Americans hospitalized for heart failure are coming up short when it comes to getting the therapy they need – especially women and minorities, say researchers at Duke University Medical Center.

A systematic review finds that implantable cardioverter defibrillators (ICDs) are safe and significantly reduce death for adults with left ventricular systolic dysfunction (Review, p. 251).